
    
      Open-label, single center study consisting of a 2 to 4 week baseline washout phase, a 12-week
      Amlodipine background treatment phase followed by a 4-week Low Dose Nebivolol/Metoprolol
      Treatment phase and a 4-week High Dose Nebivolol/Metoprolol Treatment Phase.
    
  